Eupraxia Pharmaceuticals EPRX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$778.1K (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 21.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 9.64% to 9.45% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +46,532 | 0.1% |
| BlackRock | Mutual Fund | 2026/Q3 | +140,898 | 0.2% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +85,664 | 0.2% |
| Scotiabank Global Banking and Markets, Asset Management Division | Mutual Fund | 2026/Q3 | +81,339 | 2.2% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +1,046,000 | 1.6% |
| PFM Health Sciences, LP | Hedge Fund | 2026/Q3 | +669,790 | 1.8% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +441,586 | 0.7% |
| Picton Mahoney Asset Management | Mutual Fund | 2026/Q3 | +360,878 | 0.5% |
| Woodline Partners LP | Hedge Fund | 2026/Q3 | +306,313 | 1.1% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +293,843 | 0.5% |
| DV Equities, LLC | Mutual Fund | 2026/Q3 | +276,000 | 0.4% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +271,835 | 0.8% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +269,000 | 0.4% |
| Dafna Capital Management, LLC | Hedge Fund | 2026/Q3 | +225,600 | 0.3% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +210,284 | 0.3% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 7 Mar 2026 | Richard Glickman | Independent Director | Other Derivative Disposition | -3,125 | – | – |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 6,246,800 | 9.5% | 10.4 |
| 15 Oct 2026 | 6,538,961 | 9.9% | 5.3 |
| 30 Sep 2026 | 6,798,798 | 10.3% | 11.1 |
| 15 Sep 2026 | 7,582,355 | 11.5% | 11.3 |
| 31 Aug 2026 | 7,112,440 | 10.8% | 18.5 |
| 14 Aug 2026 | 6,336,985 | 9.6% | 28.8 |
No comments yet — be the first to weigh in on EPRX.
Sign in to join the discussion.